Prostate cancer is now the most common in England, new research has found. This week, charity Prostate Cancer UK said diagnoses of the disease had overtaken breast cancer in 2022 and 2023, making it ...

The late singer and actress died at the age of 78 in January 2025 after battling several health issues throughout her life.

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

A local veteran fighting breast cancer received an unforgettable surprise from the NFL, the Super Bowl Planning Committee and ...

Author, speaker and health content creator Dr Liz O’Riordan shares her journey from consultant breast surgeon to cancer ...

The statistics are alarming. According to the American Heart Association, one in three women dies from heart disease, yet ...

The Swiss pharmaceutical company said the FDA backed a label expansion for the Pathway HER2 (4B5) test to identify patients with HR-positive, HER2-ultralow metastatic breast cancer who could be ...

Evan Meyer, Owen Cleland, and the Penta-BGHS DECA chapter have worked to show support for those affected by breast cancer and fundraise for cancer research. As the “Fight Cancer” campaign draws to a ...

The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...

One of the most important launches for Novartis in recent years is off with a bang. | One of the most important launches for ...